WallStreetZenWallStreetZen

NASDAQ: ATOS
Atossa Therapeutics Inc Stock Ownership - Who owns Atossa Therapeutics?

Insider buying vs selling

Have Atossa Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jonathan FinnDirector2024-04-1025,000$1.77
$44.25kBuy
Gregory L. WeaverFormer EVP CFO Director2023-11-1550,000$0.65
$32.50kSell
Gregory L. WeaverEVP CFO2023-06-2050,000$0.97
$48.50kBuy

1 of 1

ATOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATOS insiders and whales buy or sell their stock.

ATOS Shareholders

What type of owners hold Atossa Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Steven C. Quay7.72%9,679,716$14.52MInsider
Shuchih Chen7.26%9,095,173$13.64MInsider
Vanguard Group Inc4.53%5,675,724$8.51MInstitution
Blackrock Inc2.23%2,796,437$4.19MInstitution
Laurion Capital Management LP1.78%2,225,800$3.34MInstitution
Renaissance Technologies LLC1.02%1,284,270$1.93MInstitution
Geode Capital Management LLC0.89%1,114,924$1.67MInstitution
Gsa Capital Partners LLP0.36%449,082$673.62kInstitution
State Street Corp0.35%436,271$654.41kInstitution
Bank Of Montreal0.28%352,700$529.05kInstitution

1 of 3

ATOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATOS12.74%15.22%Net BuyingNet Buying
XFOR57.63%1.30%Net SellingNet Selling
ABOS63.98%16.58%Net Buying
ACRV46.35%53.65%Net BuyingNet Buying
CADL13.72%37.54%Net Selling

Atossa Therapeutics Stock Ownership FAQ

Who owns Atossa Therapeutics?

Atossa Therapeutics (NASDAQ: ATOS) is owned by 12.74% institutional shareholders, 15.22% Atossa Therapeutics insiders, and 72.04% retail investors. Steven C. Quay is the largest individual Atossa Therapeutics shareholder, owning 9.68M shares representing 7.72% of the company. Steven C. Quay's Atossa Therapeutics shares are currently valued at $14.71M.

If you're new to stock investing, here's how to buy Atossa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.